China · Delayed Price · Currency is CNY Suzhou Fushilai Pharmaceutical Company Description
Suzhou Fushilai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and health care raw materials in China and internationally.
The company offers lipoic acid products comprising granular alpha lipoic acid, R-lipoic acid, r-lipoic acid tromethamine salt, and 6,8-dichlorooctanoic acid ethyl ester; l-carnosine; phosphatidylcholine products, which include glycerylphosphatidylcholine; and erelcoxib API, a nonsteroidal anti-inflammatory analgesic used to relieve the pain symptoms of osteoarthritis.
Its products are used in medicines, dietary supplements, and cosmetics applications. The company also engages in research and experimental development and capital market activities.
The company exports its products to Europe, America, and Southeast Asia. Suzhou Fushilai Pharmaceutical Co., Ltd. was founded in 2000 and is based in Changshu, China.
| Country | China |
| Founded | 2000 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 524 |
| CEO | Xiangyun Qian |
Contact Details
Address: No.16 Haiwang Road Changshu, 215500 China | |
| Phone | 86 51 2528 35990 |
| Website | fuslai.com |
Stock Details
| Ticker Symbol | 301258 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000058W2 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Xiangyun Qian | Chairman and GM |
| Aijin Bian | Deputy GM, Board Secretary, Financial Director, Head of Accounting Agency and Director |
| Jiangang Lu | Deputy GM of Production and Director |
| Yi Qian | Chairman of the Board of Supervisors and Director of Human Resources and Administration |